
Second-line panitumumab as a triweekly dose for patients with wild-type <i>KRAS</i> exon 2 metastatic colorectal cancer: a single-institution experience
Author(s) -
Mohamed A. Daoud,
Mohamed A. Daoud,
Engy M. Aboelnaga,
W. S. Mohamed,
Engy M. Aboelnaga,
W. S. Mohamed
Publication year - 2016
Publication title -
cancer biology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.517
H-Index - 42
ISSN - 2095-3941
DOI - 10.20892/j.issn.2095-3941.2015.0009
Subject(s) - panitumumab , kras , exon , colorectal cancer , oncology , medicine , line (geometry) , cancer research , cancer , biology , genetics , mathematics , gene , geometry